This cutting-edge technology allows for an in-depth exploration of tumor cell complexity and heterogeneity, shedding light on the diverse gene expression patterns linked to resistance and enhancing our understanding of how the tumor microenvironment contributes to EGFR-TKI resistance. Here, EGFR is linked to neoplasm.